These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


769 related items for PubMed ID: 29522280

  • 1. Diagnostic and prognostic value of serum miR-15a and miR-16-1 expression among egyptian patients with prostate cancer.
    Zidan HE, Abdul-Maksoud RS, Elsayed WSH, Desoky EAM.
    IUBMB Life; 2018 May; 70(5):437-444. PubMed ID: 29522280
    [Abstract] [Full Text] [Related]

  • 2. Serum Levels of miR-223-3p and miR-223-5p in Prostate Diseases.
    Dülgeroğlu Y, Eroğlu O.
    Microrna; 2020 May; 9(4):303-309. PubMed ID: 33155933
    [Abstract] [Full Text] [Related]

  • 3. MiR-139-5p is Increased in the Peripheral Blood of Patients with Prostate Cancer.
    Pang C, Liu M, Fang W, Guo J, Zhang Z, Wu P, Zhang Y, Wang J.
    Cell Physiol Biochem; 2016 May; 39(3):1111-7. PubMed ID: 27562849
    [Abstract] [Full Text] [Related]

  • 4. Combinations of serum prostate-specific antigen and plasma expression levels of let-7c, miR-30c, miR-141, and miR-375 as potential better diagnostic biomarkers for prostate cancer.
    Kachakova D, Mitkova A, Popov E, Popov I, Vlahova A, Dikov T, Christova S, Mitev V, Slavov C, Kaneva R.
    DNA Cell Biol; 2015 Mar; 34(3):189-200. PubMed ID: 25521481
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Urinary microRNA-based signature improves accuracy of detection of clinically relevant prostate cancer within the prostate-specific antigen grey zone.
    Salido-Guadarrama AI, Morales-Montor JG, Rangel-Escareño C, Langley E, Peralta-Zaragoza O, Cruz Colin JL, Rodriguez-Dorantes M.
    Mol Med Rep; 2016 Jun; 13(6):4549-60. PubMed ID: 27081843
    [Abstract] [Full Text] [Related]

  • 8. Increased Expression of miR-494 in Serum of Patients with Prostate Cancer and its Potential Diagnostic Value.
    Cai B, Peng JH.
    Clin Lab; 2019 Aug 01; 65(8):. PubMed ID: 31414754
    [Abstract] [Full Text] [Related]

  • 9. MiR-145 detection in urinary extracellular vesicles increase diagnostic efficiency of prostate cancer based on hydrostatic filtration dialysis method.
    Xu Y, Qin S, An T, Tang Y, Huang Y, Zheng L.
    Prostate; 2017 Jul 01; 77(10):1167-1175. PubMed ID: 28617988
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Using Genetic and Epigenetic Markers to Improve Differential Diagnosis of Prostate Cancer and Benign Prostatic Hyperplasia by Noninvasive Methods in Mexican Patients.
    Sánchez BE, Aguayo A, Martínez B, Rodríguez F, Marmolejo M, Svyryd Y, Luna L, Muñoz LA, Jiménez MA, Sotomayor M, Vargas V F, Mutchinick OM.
    Clin Genitourin Cancer; 2018 Aug 01; 16(4):e867-e877. PubMed ID: 29571584
    [Abstract] [Full Text] [Related]

  • 16. Five microRNAs in serum as potential biomarkers for prostate cancer risk assessment and therapeutic intervention.
    Guo X, Han T, Hu P, Guo X, Zhu C, Wang Y, Chang S.
    Int Urol Nephrol; 2018 Dec 01; 50(12):2193-2200. PubMed ID: 30324582
    [Abstract] [Full Text] [Related]

  • 17. Early diagnostic role of PSA combined miR-155 detection in prostate cancer.
    Guo T, Wang XX, Fu H, Tang YC, Meng BQ, Chen CH.
    Eur Rev Med Pharmacol Sci; 2018 Mar 01; 22(6):1615-1621. PubMed ID: 29630104
    [Abstract] [Full Text] [Related]

  • 18. MMP26: A potential biomarker for prostate cancer.
    Cheng T, Li F, Wei R, Lv MQ, Zhou Y, Dai Y, Yuan Y, Jiang GY, Ma D, Gao QL.
    J Huazhong Univ Sci Technolog Med Sci; 2017 Dec 01; 37(6):891-894. PubMed ID: 29270749
    [Abstract] [Full Text] [Related]

  • 19. Prognostic implications of tissue and serum levels of microRNA-128 in human prostate cancer.
    Sun X, Yang Z, Zhang Y, He J, Wang F, Su P, Han J, Song Z, Fei Y.
    Int J Clin Exp Pathol; 2015 Dec 01; 8(7):8394-401. PubMed ID: 26339409
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 39.